Unbiased AI-powered news
5 stories related to this topic, newest first.
The IndependentThe National Institute for Health and Care Excellence has approved nusinersen and risdiplam for routine NHS use in England. The treatments were previously available only through a special access scheme. Muscular Dystrophy UK reports that the therapies have enabled 73 children wit…
dailywire.comJordan Peterson has been absent from public view since May 2025 following a severe flare-up of chronic inflammatory response syndrome that led to pneumonia, sepsis and nearly a month in intensive care. His family attributes the symptoms to akathisia caused by prior benzodiazepine…
Substrate placeholder — needs reviewHealth and Human Services Secretary Robert F. Kennedy Jr. is advocating for reduced restrictions on 14 synthetic peptides currently classified as Category 2 by the FDA. This move aims to allow licensed compounding pharmacies to produce them for patient use. Physicians have shared…
insidermonkey.comA report highlights rare diseases impacting more than 300 million individuals worldwide. It advocates for removing structural obstacles in treatment development. The piece proposes viewing certain therapies as molecular surgery rather than traditional drug treatments.
Substrate placeholder — needs reviewMajor US health insurers have implemented changes to streamline the prior authorization process for specific treatments, according to industry groups. These adjustments aim to reduce administrative burdens on physicians. The changes follow federal recommendations issued earlier t…